[IgD paraproteinemia in immunocytoma]. 1988

G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
Medizinische Poliklinik, Ludwig-Maximilians-Universität München.

The extremely rare immunocytoma with IgD-paraproteinemia was observed in a 65-year-old man with infiltrations of the throat and the sinuses. The diagnosis was made on the basis of several biopsy specimens and serum immunoelectrophoresis. In spite of intensive chemotherapy and radiotherapy a remission was not achieved. In the final stages, a transformation into an immunoblastic sarcoma accompanied by an acute plasma-cell leukemia appeared. The patient died 11 months after diagnosis from renal failure due to infiltrations of the kidneys. The poor prognosis and the poor response to radiotherapy may be associated with the IgD-paraproteinemia. Serum electrophoresis and immunoelectrophoresis proved to be sensitive parameters for monitoring tumor recurrence.

UI MeSH Term Description Entries
D007072 Immunoglobulin D An immunoglobulin which accounts for less than 1% of plasma immunoglobulin. It is found on the membrane of many circulating B LYMPHOCYTES. IgD,IgD1,IgD2
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D010265 Paraproteinemias A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin. Gammapathy, Monoclonal,Gammopathy, Monoclonal,Monoclonal Gammopathies,Paraimmunoglobulinemia,Paraimmunoglobulinemias,Paraproteinemia,Plasma Cell Dyscrasias,Monoclonal Gammapathies,Monoclonal Gammopathy,Cell Dyscrasia, Plasma,Dyscrasia, Plasma Cell,Monoclonal Gammapathy,Plasma Cell Dyscrasia
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
November 1982, Deutsche medizinische Wochenschrift (1946),
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
January 1993, Acta oncologica (Stockholm, Sweden),
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
January 1976, Vutreshni bolesti,
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
March 1975, Vnitrni lekarstvi,
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
January 1990, Vnitrni lekarstvi,
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
May 1980, Journal of immunology (Baltimore, Md. : 1950),
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
January 2010, Neurology research international,
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
February 1989, The Journal of dermatology,
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
January 1990, Dermatologica,
G Papakonstantinou, and C Eisenhut, and H Füessl, and R Hehlmann
August 1978, Minerva medica,
Copied contents to your clipboard!